Vertex Pharmaceuticals Inc. buy Truist Financial Co.
Start price
31.01.24
/
50%
€400.85
Target price
31.01.25
€470.15
Performance (%)
-2.06%
Price
10.05.24
€392.60
Summary
This prediction is currently active. With a performance of -2.06%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 31.01.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 5.368% | 5.368% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Truist Financial Co. from $456.00 to $508.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€332.85
04.10.23
04.10.23
€434.43
04.10.24
04.10.24
17.95%
10.05.24
10.05.24